News Articles Tagged: CRC

Baicalin's Anticancer Potential: A Natural Compound Targeting Digestive System Tumors

Explore the anticancer potential of Baicalin, a natural flavonoid from Scutellaria baicalensis, focusing on its mechanisms against digestive system tumors like CRC and HCC.

The Role of Mithramycin A in Targeting Cancer Stem Cells for Improved Outcomes

Delve into how Mithramycin A combats cancer stem cells (CSCs), a key factor in tumor recurrence and drug resistance, especially in colorectal cancer. Learn about its mechanisms and potential applications with NINGBO INNO PHARMCHEM CO.,LTD.

Fruquintinib: A Targeted Therapy for Advanced Colorectal Cancer Patients

Discover how Fruquintinib's targeted approach and clinical trial successes offer new hope for patients with previously treated advanced colorectal cancer.

Navigating Fruquintinib Treatment: Efficacy, Safety, and Patient Journey Insights

NINGBO INNO PHARMCHEM CO.,LTD. shares insights into the patient journey with Fruquintinib, covering its efficacy, safety profile, and practical considerations for managing this advanced CRC therapy.

NINGBO INNO PHARMCHEM CO.,LTD.: Leading the Way in Targeted Colorectal Cancer Therapies with SN38-Glucose Conjugates

NINGBO INNO PHARMCHEM CO.,LTD. is innovating targeted colorectal cancer therapies with SN38-glucose conjugates, enhancing drug delivery and efficacy by targeting cancer cell metabolism.